CIK 0001583648 · Non-accelerated filer<br>Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 300784346
- Phone
- (484) 253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,725,861
- in 7 filings, $11.7M under 10b5-1 plans
Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,154 | $7.14 | $15K | 2,154 |
| 2026-06-17 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,148 | $9.08 | $20K | 4,302 |
| 2026-06-17 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −2,390 | $110.26 | $264K | 1,912 |
| 2026-06-17 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −1,887 | $111.31 | $210K | 25 |
| 2026-06-17 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −25 | $112.23 | $3K | 0 |
| 2026-06-17 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,154 | 8,627 | ||
| 2026-06-17 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,148 | 8,592 | ||
| 2026-06-12 | Korenberg Matthew E CFO, Treasurer | Option exercise | +1,000 | $13.60 | $14K | 1,000 |
| 2026-06-12 | Korenberg Matthew E CFO, Treasurer | Option exercise · Stock Option (Right to Buy) | −1,000 | 166,100 | ||
| 2026-06-10 | KIRITSY CHRISTOPHER P Director | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2026-06-10 | JENKINS GEORGE M Director | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2026-06-10 | HERON ELAINE J Director | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2026-06-10 | Doux John Director | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2026-06-10 | Davis Todd C Director | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2026-06-10 | Wessel Tadd S. Director | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2026-05-20 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,154 | $7.14 | $15K | 2,154 |
| 2026-05-20 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,148 | $9.08 | $20K | 4,302 |
| 2026-05-20 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −3,363 | $110.35 | $371K | 939 |
| 2026-05-20 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −891 | $111.30 | $99K | 48 |
| 2026-05-20 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −48 | $111.90 | $5K | 0 |
Page 5 of 12 · 232 trades